1 Introduction to Research & Analysis Reports
1.1 Gemtuzumab Ozogamicin Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gemtuzumab Ozogamicin Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gemtuzumab Ozogamicin Drugs Overall Market Size
2.1 Global Gemtuzumab Ozogamicin Drugs Market Size: 2022 VS 2029
2.2 Global Gemtuzumab Ozogamicin Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Gemtuzumab Ozogamicin Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Gemtuzumab Ozogamicin Drugs Players in Global Market
3.2 Top Global Gemtuzumab Ozogamicin Drugs Companies Ranked by Revenue
3.3 Global Gemtuzumab Ozogamicin Drugs Revenue by Companies
3.4 Global Gemtuzumab Ozogamicin Drugs Sales by Companies
3.5 Global Gemtuzumab Ozogamicin Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gemtuzumab Ozogamicin Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gemtuzumab Ozogamicin Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gemtuzumab Ozogamicin Drugs Players in Global Market
3.8.1 List of Global Tier 1 Gemtuzumab Ozogamicin Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Gemtuzumab Ozogamicin Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Gemtuzumab Ozogamicin Drugs Market Size Markets, 2022 & 2029
4.1.2 5mg/Vial
4.1.3 4.5mg/Vial
4.2 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue & Forecasts
4.2.1 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2023
4.2.2 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue, 2024-2029
4.2.3 By Type – Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
4.3 By Type – Global Gemtuzumab Ozogamicin Drugs Sales & Forecasts
4.3.1 By Type – Global Gemtuzumab Ozogamicin Drugs Sales, 2018-2023
4.3.2 By Type – Global Gemtuzumab Ozogamicin Drugs Sales, 2024-2029
4.3.3 By Type – Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
4.4 By Type – Global Gemtuzumab Ozogamicin Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Gemtuzumab Ozogamicin Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue & Forecasts
5.2.1 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2023
5.2.2 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue, 2024-2029
5.2.3 By Application – Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
5.3 By Application – Global Gemtuzumab Ozogamicin Drugs Sales & Forecasts
5.3.1 By Application – Global Gemtuzumab Ozogamicin Drugs Sales, 2018-2023
5.3.2 By Application – Global Gemtuzumab Ozogamicin Drugs Sales, 2024-2029
5.3.3 By Application – Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
5.4 By Application – Global Gemtuzumab Ozogamicin Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Gemtuzumab Ozogamicin Drugs Market Size, 2022 & 2029
6.2 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue & Forecasts
6.2.1 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue, 2018-2023
6.2.2 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue, 2024-2029
6.2.3 By Region – Global Gemtuzumab Ozogamicin Drugs Revenue Market Share, 2018-2029
6.3 By Region – Global Gemtuzumab Ozogamicin Drugs Sales & Forecasts
6.3.1 By Region – Global Gemtuzumab Ozogamicin Drugs Sales, 2018-2023
6.3.2 By Region – Global Gemtuzumab Ozogamicin Drugs Sales, 2024-2029
6.3.3 By Region – Global Gemtuzumab Ozogamicin Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.4.2 By Country – North America Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.4.3 US Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.4.4 Canada Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.4.5 Mexico Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.5.2 By Country – Europe Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.5.3 Germany Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.4 France Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.5 U.K. Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.6 Italy Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.7 Russia Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.5.9 Benelux Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.6.2 By Region – Asia Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.6.3 China Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.4 Japan Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.5 South Korea Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.6.7 India Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.7.2 By Country – South America Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.7.3 Brazil Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.7.4 Argentina Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Gemtuzumab Ozogamicin Drugs Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Gemtuzumab Ozogamicin Drugs Sales, 2018-2029
6.8.3 Turkey Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8.4 Israel Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
6.8.6 UAE Gemtuzumab Ozogamicin Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Gemtuzumab Ozogamicin Drugs Major Product Offerings
7.1.4 Pfizer Gemtuzumab Ozogamicin Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
8 Global Gemtuzumab Ozogamicin Drugs Production Capacity, Analysis
8.1 Global Gemtuzumab Ozogamicin Drugs Production Capacity, 2018-2029
8.2 Gemtuzumab Ozogamicin Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Gemtuzumab Ozogamicin Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gemtuzumab Ozogamicin Drugs Supply Chain Analysis
10.1 Gemtuzumab Ozogamicin Drugs Industry Value Chain
10.2 Gemtuzumab Ozogamicin Drugs Upstream Market
10.3 Gemtuzumab Ozogamicin Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gemtuzumab Ozogamicin Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のゲムツズマブ オゾガマイシン市場予測2023-2029：5mg/バイアル、4.5mg/バイアル |
| 【英語タイトル】Gemtuzumab Ozogamicin Drugs Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5582 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：78 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のゲムツズマブ オゾガマイシン市場規模と予測を収録しています。・世界のゲムツズマブ オゾガマイシン市場：売上、2018年-2023年、2024年-2029年 ・世界のゲムツズマブ オゾガマイシン市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のゲムツズマブ オゾガマイシン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「5mg/バイアル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 ゲムツズマブ オゾガマイシンのグローバル主要企業は、Pfizerなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、ゲムツズマブ オゾガマイシンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のゲムツズマブ オゾガマイシン市場：タイプ別、2018年-2023年、2024年-2029年 世界のゲムツズマブ オゾガマイシン市場：タイプ別市場シェア、2022年 ・5mg/バイアル、4.5mg/バイアル 世界のゲムツズマブ オゾガマイシン市場：用途別、2018年-2023年、2024年-2029年 世界のゲムツズマブ オゾガマイシン市場：用途別市場シェア、2022年 ・病院、薬局 世界のゲムツズマブ オゾガマイシン市場：地域・国別、2018年-2023年、2024年-2029年 世界のゲムツズマブ オゾガマイシン市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるゲムツズマブ オゾガマイシンのグローバル売上、2018年-2023年 ・主要企業におけるゲムツズマブ オゾガマイシンのグローバル売上シェア、2022年 ・主要企業におけるゲムツズマブ オゾガマイシンのグローバル販売量、2018年-2023年 ・主要企業におけるゲムツズマブ オゾガマイシンのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer ************************************************************* ・調査・分析レポートの概要 ゲムツズマブ オゾガマイシン市場の定義 市場セグメント 世界のゲムツズマブ オゾガマイシン市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のゲムツズマブ オゾガマイシン市場規模 世界のゲムツズマブ オゾガマイシン市場規模：2022年 VS 2029年 世界のゲムツズマブ オゾガマイシン市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのゲムツズマブ オゾガマイシンの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のゲムツズマブ オゾガマイシン製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：5mg/バイアル、4.5mg/バイアル ゲムツズマブ オゾガマイシンのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、薬局 ゲムツズマブ オゾガマイシンの用途別グローバル売上・予測 ・地域別市場分析 地域別ゲムツズマブ オゾガマイシン市場規模 2022年と2029年 地域別ゲムツズマブ オゾガマイシン売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer ... |
Gemtuzumab ozogamicin is a drug-linked monoclonal antibody (an antibody-drug conjugate) that was used to treat acute myeloid leukemia from 2000 to 2010.
This report aims to provide a comprehensive presentation of the global market for Gemtuzumab Ozogamicin Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemtuzumab Ozogamicin Drugs. This report contains market size and forecasts of Gemtuzumab Ozogamicin Drugs in global, including the following market information:
Global Gemtuzumab Ozogamicin Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Gemtuzumab Ozogamicin Drugs Market Sales, 2018-2023, 2024-2029, (kUnits)
Global top five Gemtuzumab Ozogamicin Drugs companies in 2022 (%)
The global Gemtuzumab Ozogamicin Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
5mg/Vial Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gemtuzumab Ozogamicin Drugs include Pfizer. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gemtuzumab Ozogamicin Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gemtuzumab Ozogamicin Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (kUnits)
Global Gemtuzumab Ozogamicin Drugs Market Segment Percentages, by Type, 2022 (%)
5mg/Vial
4.5mg/Vial
Global Gemtuzumab Ozogamicin Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (kUnits)
Global Gemtuzumab Ozogamicin Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Gemtuzumab Ozogamicin Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (kUnits)
Global Gemtuzumab Ozogamicin Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gemtuzumab Ozogamicin Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Gemtuzumab Ozogamicin Drugs revenues share in global market, 2022 (%)
Key companies Gemtuzumab Ozogamicin Drugs sales in global market, 2018-2023 (Estimated), (kUnits)
Key companies Gemtuzumab Ozogamicin Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gemtuzumab Ozogamicin Drugs, market overview.
Chapter 2: Global Gemtuzumab Ozogamicin Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Gemtuzumab Ozogamicin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gemtuzumab Ozogamicin Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Gemtuzumab Ozogamicin Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のゲムツズマブ オゾガマイシン市場予測2023-2029：5mg/バイアル、4.5mg/バイアル] (コード：MMG23JU5582)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のゲムツズマブ オゾガマイシン市場予測2023-2029：5mg/バイアル、4.5mg/バイアル]についてメールでお問い合わせ |
